Elsevier

Journal of Hepatology

Volume 39, Issue 2, August 2003, Pages 231-238
Journal of Hepatology

Quality of life and cognitive function in hepatitis C at different stages of liver disease

https://doi.org/10.1016/S0168-8278(03)00189-2Get rights and content

Abstract

Background/Aims: Hepatitis C has been associated with a decrease in quality of life and with neurological abnormalities. The aim of our study was to investigate the relationship between quality of life and cognitive function.

Methods: Quality of life, clinical variables and neuropsychological function were evaluated in 120 patients with hepatitis C (mild chronic hepatitis, compensated cirrhosis and decompensated cirrhosis) and in healthy controls (n=40, in each group).

Results: Patients with chronic hepatitis or compensated cirrhosis showed a decrease in quality of life, in spite of unimpaired neuropsychological tests. Patients with decompensated cirrhosis exhibited a further decrease in quality of life and neuropsychological abnormalities. The decrease in quality of life was associated with the severity of liver failure, neuropsychological abnormalities and treatment with beta-blockers or diuretics. However, in the multivariable analysis, only treatment with beta-blockers or diuretics (which was limited to decompensated cirrhosis) was independently associated with quality of life.

Conclusions: Hepatitis C causes a decrease in quality of life even in the absence of major cognitive impairment. The mechanisms that worsen quality of life are unknown. However, in cirrhotic outpatients with prior decompensations, treatment with beta-blockers or diuretics appears to have an important effect on quality of life.

Introduction

Hepatitis C is associated with an impairment in health-related quality of life (HRQOL) [1], [2], [3]. Several factors that are common in patients with hepatitis C virus (HCV) infection may determine the decrease in HRQOL, such as low socioeconomic level or intravenous drug abuse [2], medical or psychiatric comorbidities [4], [5] or the labeling effect of establishing the diagnosis of HCV infection [6], [7]. However, the mechanisms underlying the impairment in HRQOL have not been elicited. It has been proposed that hepatitis C may cause some sort of neuropsychological impairment that affects patients’ perceptions of health [8]. In addition, advanced liver disease has been associated with a marked decrease in HRQOL [9], that may be due to minimal hepatic encephalopathy [10]. However, the majority of the studies in patients with HCV have been focused on patients without advanced cirrhosis, which is the group that develops minimal hepatic encephalopathy.

We undertook a study to evaluate HRQOL and cognitive function in patients with hepatitis C at different stages of liver disease. We assessed three groups of patients that covered clinically relevant stages: chronic hepatitis, cirrhosis without prior decompensations and cirrhosis with prior decompensations (ascites, gastrointestinal bleeding or hepatic encephalopathy). Our aim was to investigate the influence of cognitive function on HRQOL and explore possible associations between HRQOL and the clinical characteristics of the patients. For this purpose we controlled for age, gender and years of education, which are variables that are known to influence cognitive function, and we included a healthy control group to avoid local biases in the performance of neuropsychological tests.

Section snippets

Subjects

Patients with hepatitis C (HCV antibody and RNA-HCV positive) were selected from the outpatient clinic at Hospital Vall d'Hebron before receiving antiviral therapy. We selected middle aged patients, above 45 years (because cirrhosis is uncommon below this age) and below 65 years (to avoid the confounding effect of advanced age). Patients were excluded if they showed one of the following characteristics: marked cognitive disorder (mini-mental test <27), impaired autonomy (Barthel <100%),

Results

Health-related quality of life scores showed deterioration with the severity of the liver disease for most of the domains of the SF-36 (Table 2). The analysis of variance showed that scores were lower (P<0.001) the more severe the liver damage for all the domains, except for role emotional (P=0.4) and mental health (P=0.18). The Beck Depression Inventory and the State-Trait Anxiety Inventory, which are more appropriate than the SF-36 to detect symptoms of depression or anxiety, showed increased

Discussion

The results of this study indicate that patients with hepatitis C have an impairment in quality of life even in the absence of significant cognitive abnormalities. Our results argue against a major role of cognitive function in mediating the decrease in HRQOL, because we observed the characteristic impairment of the SF-36 scores in a group of patients with HCV and chronic hepatitis or compensated cirrhosis that did not exhibit important neuropsychological abnormalities. Recent studies have

Acknowledgements

Montse Flavià, PhD was supported by a grant from Schering-Plough International. Study supported in part by ‘Red Nacional de Investigación en Hepatologı́a y Gastroenterologı́a (RNIHG)’, Instituto de Salud Carlos III, (project C03/02).

References (39)

  • H.F Lui et al.

    Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol and isosorbide mononitrate

    Gastroenterology

    (2002)
  • Z.M Younossi

    Chronic liver disease and health-related quality of life

    Gastroenterology

    (2001)
  • A Srivastava et al.

    Fitness to drive in patients with cirrhosis and portal-systemic shunting: a pilot study evaluating driving performance

    J Hepatol

    (1994)
  • G.L Davis et al.

    Assessing health-related quality of life in chronic hepatitis C using the sickness impact profile

    Clin Ther

    (1994)
  • G.R Foster et al.

    Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis

    Hepatology

    (1998)
  • Bonkowsky HL, Woolley JM, Consensus Interferon Study Group. Reduction of health-related quality of life in chronic...
  • A.J Rodger et al.

    The impact of diagnosis of hepatitis C virus on quality of life

    Hepatology

    (1999)
  • R.S Koff

    Impaired health-related quality of life in chronic hepatitis C: the how but not the why

    Hepatology

    (1999)
  • J.C Quero et al.

    Subclinical hepatic encephalopathy

    Semin Liver Dis

    (1996)
  • Cited by (182)

    View all citing articles on Scopus
    View full text